GLP-1 potentiators from hedychium coronarium and their applications
US9150482B2 · kind B2 · utility
2Cited by
0References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 6, 2013 |
| Grant date | Oct 6, 2015 |
| Priority date | — |
| Expiry date | Jun 6, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2603/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound for controlling blood glucose level has a structure shown in Formula I:wherein R5-R8 are as defined herein. A method for controlling blood glucose level includes administering to a subject in need thereof a compound of Formula I. The method further includes administering to the subject a GLP-1 receptor ligand. The compound and the GLP-1 receptor ligand may be administered together. The compound may be Galanal A or Galanal B. The GLP-1 receptor ligand may be GLP-1 or exendin-4.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.